Physiological and pharmacological properties of adenosine: therapeutic implications.
about
Antinociceptive and antiedematogenic properties and acute toxicity of Tabebuia avellanedae Lor. ex Griseb. inner bark aqueous extractSmall molecule-driven direct conversion of human pluripotent stem cells into functional osteoblasts5'-Nucleotidase: molecular structure and functional aspectsActivation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus.Cellular defenses against excitotoxic insults.Primary structure and functional expression of a cDNA encoding the bile canalicular, purine-specific Na(+)-nucleoside cotransporter.Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A1 receptor in a manner different from its classical agonistsPaeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptorAdenosine A3 receptor stimulation and cerebral ischemiaCircadian variations of adenosine and of its metabolism. Could adenosine be a molecular oscillator for circadian rhythms?ATP--a fast neurotransmitter.Thermoregulatory effects of 5'-N-ethylcarboxamidoadenosine in rabbits.Adenosine A(2A) receptor mRNA regulation by nerve growth factor is TrkA-, Src-, and Ras-dependent via extracellular regulated kinase and stress-activated protein kinase/c-Jun NH(2)-terminal kinase.Effects of N6-cyclopentyl adenosine and 8-cyclopentyl-1,3-dipropylxanthine on N-methyl-D-aspartate induced seizures in mice.Production and Breeding of Transgenic Cloned Pigs Expressing Human CD73.Purinoceptors: from history to recent progress. A review.Chronic adenosine A1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in mice.Acute effect of low dose theophylline on the circulatory disturbances of cirrhosis.Modelling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophylline.Effects of chronic administration of adenosine A1 receptor agonist and antagonist on spatial learning and memory.Modified hemoglobin solution, with desired pharmacological properties, does not activate nuclear transcription factor NF-kappa B in human vascular endothelial cells.Expression of adhesion molecules and von Willebrand factor in human coronary artery endothelial cells incubated with differently modified hemoglobin solutions.AMP N(1)-oxide, a unique compound of royal jelly, induces neurite outgrowth from PC12 cells via signaling by protein kinase A independent of that by mitogen-activated protein kinase.Activation of protein kinase A and atypical protein kinase C by A(2A) adenosine receptors antagonizes apoptosis due to serum deprivation in PC12 cells.Vasodilator responses to adenosine and hyperemia are mediated by A(1) and A(2) receptors in the cat vascular bed.Essential role of cAMP-response element-binding protein activation by A2A adenosine receptors in rescuing the nerve growth factor-induced neurite outgrowth impaired by blockage of the MAPK cascade.[3H]adenosine transport in synaptoneurosomes of postmortem human brain.Cardiovascular and pulmonary response to oral administration of ATP in rabbits.Effects of adenosine on NANC bronchoconstriction in anaesthetized guinea-pigs.Temporal variations of adenosine metabolism in human blood.
P2860
Q24804953-3E4EB1FD-FAC6-416A-8AFB-8C5DCAEE1677Q27333060-BF82A23D-24C8-418F-A1CB-6D4805568F26Q28620587-4C60A12A-834B-416D-B069-A09C4169E3FDQ33797583-EA4E599E-B006-4A41-BE03-9AD96DD873E0Q34190147-54EBE1C8-F5E7-49BB-8131-AD8D1CDDA921Q34312670-EABFE562-EF8C-499F-B1A6-9DC5992D2FAAQ35545024-DDFE3C27-DA50-4F51-B112-EEA4120AA0BFQ35545909-536616BE-2D36-4899-B4D1-1E5F01A6AB79Q36185246-E1199DA6-3DF8-4268-B68B-AF12A8B676BCQ40467404-CD787679-4FBC-4C80-A8D7-552CC53A8F1BQ40487593-E94E6749-6788-4BD3-9F6F-E1EE0685A5FBQ40653469-D8A91FC6-FE5F-4159-890D-400369A4B3D1Q40914124-6F916C84-AA27-4912-8FF3-F9C5AF3831E7Q41154127-F3120BB3-059F-4CA6-A363-579567DD309AQ41159327-DAD51500-7B80-42BC-B8A7-79D2A96098DDQ41255014-2C86CAFE-FFC5-4A22-9554-57C57F21827DQ41807674-AFAB0E74-F402-4C06-9373-49C3AAB4E0CBQ41962307-8C89D612-05A0-432B-A8B6-DDEA8CD6677FQ42079975-1F201190-5E41-42C4-9B25-DB86A2334684Q42203337-BE871F82-43CB-4A22-973D-104A4D0531F7Q42436311-4FB6E54C-AD88-4CFF-A287-E220089BA2A6Q42436315-E1C867AE-CC3B-47E5-BCEB-742D1C626EC7Q42923517-413AE29B-B90A-43E3-9254-B33BD37C9EBDQ43559421-770D06D4-DA17-4C95-B057-9B6DE0B85CE3Q43993561-26BB196F-675C-449C-BFAE-ADB86C2C4E56Q44061969-9C133F7D-5BD7-44A6-AED3-83CC59B22D70Q48271188-A4CA1CD6-B1C6-492E-A7D7-072263594C81Q50511467-F02B3F92-BC51-4522-872D-0AAF9F0BFEADQ51573879-E74FBCE8-33A7-4FFE-9367-BCC1EE36D16DQ54528677-07BCE932-29FB-49D7-BE45-47AF162F0E93
P2860
Physiological and pharmacological properties of adenosine: therapeutic implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Physiological and pharmacological properties of adenosine: therapeutic implications.
@en
Physiological and pharmacological properties of adenosine: therapeutic implications.
@nl
type
label
Physiological and pharmacological properties of adenosine: therapeutic implications.
@en
Physiological and pharmacological properties of adenosine: therapeutic implications.
@nl
prefLabel
Physiological and pharmacological properties of adenosine: therapeutic implications.
@en
Physiological and pharmacological properties of adenosine: therapeutic implications.
@nl
P2093
P1433
P1476
Physiological and pharmacological properties of adenosine: therapeutic implications.
@en
P2093
P304
P356
10.1016/0024-3205(91)90043-B
P407
P577
1991-01-01T00:00:00Z